These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12630585)

  • 1. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Andraws R; Berger JS; Brown DL
    JAMA; 2005 Jun; 293(21):2641-7. PubMed ID: 15928286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection.
    Hammerschlag MR
    Circulation; 2002 Oct; 106(15):e65-6; author reply e65-6. PubMed ID: 12370232
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients.
    Jha HC; Srivastava P; Divya A; Prasad J; Mittal A
    APMIS; 2009 Dec; 117(12):905-11. PubMed ID: 20078556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
    Ismail A; Khosravi H; Olson H
    Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction.
    Pilote L; Green L; Joseph L; Richard H; Eisenberg MJ
    Am Heart J; 2002 Feb; 143(2):294-300. PubMed ID: 11835034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
    Muhlestein JB
    Curr Atheroscler Rep; 2000 Jul; 2(4):336-41. PubMed ID: 11122763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol].
    Vergassola R; Mazzoli S; Pazzagli L; Rabatti L; Abbate R; Taddei V; Acciai S
    Minerva Cardioangiol; 2000 Dec; 48(12):411-25. PubMed ID: 11253326
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
    Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
    Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.
    Gelfand EV; Cannon CP
    Am Heart J; 2004 Feb; 147(2):202-9. PubMed ID: 14760314
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The failure of antibiotics to prevent heart attacks.
    Taylor-Robinson D; Boman J
    BMJ; 2005 Aug; 331(7513):361-2. PubMed ID: 16096289
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases.
    Turkoglu C; Sonmez E; Aydinli A
    New Microbiol; 2004 Jul; 27(3):229-34. PubMed ID: 15460525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.